Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder

NCT: NCT05977634 · ACTIVE_NOT_RECRUITING

NCT IDNCT05977634
StatusACTIVE_NOT_RECRUITING
Start Date2023-09-30
Completion2026-08-30

Brief Summary

This study was designed to assess the efficacy of trans cutaneous tibial nerve stimulation on symptoms of overactive bladder in women with idiopathic overactive bladder

Frequently Asked Questions

What is Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder?

Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder is a clinical trial registered under NCT05977634. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05977634?

The current status of NCT05977634 (Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder) is: ACTIVE_NOT_RECRUITING.

When did Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder start?

Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder started on 2023-09-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑